Martin Götting brings a wealth of experience in the vaccine industry with over 20 years at Behringwerke AG and Chiron Vaccines International serving as, among others, Global Head of Production- and Sales Logistics and Director Commercial Operations. In 2005 he joined Intercell AG (today Valneva), a company focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases, as Vice-President Marketing, Sales & Supply. He holds degrees in wholesale and foreign trade, pharmaceutical sales and a qualification as Legal Trade General Manager Austria.
In 2009 he founded Capricorn Consilium GmbH, Vienna, a company dedicated to consult and provide interim management predominantly to small and medium sized vaccine companies. In this capacity he contributed to numerous licensing, partnering, funding, M&A and business development activities in the vaccine industry. During this period, he has also been appointed as Chief Business Officer for AVIR Green Hills Biotechnology, an Austrian vaccine company, being in charge of Business Development, Finance, Funding, Strategy, Human Resources, Corporate Communications, Legal, and Supply Chain Management.
Martin joined Vacthera in March 2018 as CEO.